<DOC>
	<DOCNO>NCT01422317</DOCNO>
	<brief_summary>The object study evaluate effect high-dose ethylester concentrate n-3 fatty acid administer early acute myocardial infarction subsequent cardiac event serum lipids.The second purpose study assess impact high-dose n-3 fatty acid several marker coagulation , inflammation , endothelial dysfunction lipid peroxidation . Re-investigation intend prolonged wash-out-period .</brief_summary>
	<brief_title>Effects High-dose n-3 Fatty Acids Clinical Outcome Serum Lipids - Omacor Following Acute Myocardial Infarction</brief_title>
	<detailed_description>Results epidemiologic study clinical trial indicate moderate dos n-3 unsaturated fatty acid reduce risk cardiovascular disease ( CVD ) may improve prognosis . N-3 fatty acid several beneficial cardiovascular property ( 1-3 ) , include antiatherothrombotic , antiarrhythmic , antihypertensive effect , especially noted triacylglycerol-reducing ability ( 3-7 ) . These effect may translate improved clinical outcome patient coronary artery disease ( CAD ) ( 8 ) . The pronounced effect obtain moderate dos n-3 fatty acid supplementation may suggest even strong effect pharmacologic dos . The object study therefore assess effect high-dose ethylester concentrate n-3 fatty acid compare corn oil administer early ( 4-8 day ) acute myocardial infarction ( MI ) , fatal non-fatal subsequent cardiac event ( cardiac death , resuscitation , recurrent myocardial infarction ( MI ) angina pectoris ) , 2 y follow-up ( median 18 month ) . We hypothesize high-dose n-3 fatty acid would improve serum lipid population , beneficially influence several marker coagulation , endothelial dysfunction inflammation . Three hundred patient acute myocardial infarction ( MI ) recruit one hospital center ( Central Hospital Rogaland , Stavanger , Norway ) September 1995 December 1996 . All patient include fourth eighth day acute myocardial infarction ( MI ) . All patient randomly assign receive 2 gelatin capsule Omacor-R ( Pronova AS , Oslo ) corn oil twice day . Each capsule contain either 850-882 mg eicosapentaenoic acid ( EPA ) docosahexaenoic acid ( DHA ) ethylesters average ratio eicosapentaenoic acid ( EPA ) docosahexaenoic acid ( DHA ) 1:2 amount corn oil . α-Tocopherol ( 4 mg ) add capsule . The capsule administer double-blind manner 12-24 month . A detailed patient history record clinical examination perform . The electrocardiogram scrutinize infarct location . The recent injury classify anterior inferior Q-wave infarction non-Q-wave infarction . Treatment initiate immediately inclusion collection baseline blood sample . The study approve Regional Ethics Committee Western Norway . Clinical follow-up , include blood test electrocardiogram recording , repeat 6 wk , 6 mo , 1 , 18 mo , , patient , 2 ys start treatment . A deviation 2 wk first follow-up ≤1 mo later follow-ups allow . All cardiac event ongoing medication record . Cardiac event define cardiac death , resuscitation , recurrent myocardial infarction ( MI ) , unstable angina . Revascularization death cause also record . The study close end 1997 . The median follow-up time ( ignore event except death ) 1.5 . Analyses serum triacylglycerols , total cholesterol high-density lipoprotein ( HDL ) -cholesterol perform inclusion , 6 week , 6 12 month . In addition , analyse marker inflammation [ high-sensitivity-C-reactive protein ( CRP ) , CD-40 Ligand ( CD40L ) ] , coagulation [ D-Dimer , fibrinogen , tissue factor , activate factor XII ( FXIIa ) ] , endothelial dysfunction [ adhesion molecule E-selectin Intra-Cellular Adhesion Molecule-1 ( ICAM-1 ) , homocysteine ) ] , Thiobarbituric Acid Reactive Substances ( TBARS ) marker oxidative burden n-3 fatty acid , perform different time point follow-up , evaluate influence n-3 fatty acid marker , assess prognostic ability follow myocardial infarction ( MI ) . Moreover , holo-transcobalamin ( holoTC ) , methylmalonic acid ( MMA ) , n-Terminal pro-Brain Natriuretic Peptide ( NT-proBNP ) , matrix metalloproteinases-9 ( MMP-9 ) , Pregnancy-associated plasma protein A ( PAPP-A ) , myeloperoxidase ( MPO ) , CD40 Ligand ( CD40L ) measure also order evaluate prognostic ability follow myocardial infarction ( MI ) . After closure main study , purpose evaluate prognosis study subject prolong wash-out period . Publications study : 1 . Nilsen DWT , Albrektsen G , Landmark K , Moen S , Aarsland T , Woie L. Effects high-dose concentrate n-3 fatty acid corn oil introduce early acute myocardial infarction serum triacylglycerol HDL cholesterol . Am J Clin Nutr 2001 ; 74:50-6 . 2 . Grundt H , Nilsen DW , Mansoor MA , Hetland Ø , Nordøy A . Reduction homocysteine n-3 polyunsaturated fatty acid 1 year randomise double-blind study follow acute myocardial infarction : effect endothelial adhesion property . Pathophysiol Haemost Thromb . 2003 Mar-Apr ; 33 ( 2 ) :88-95 . 3 . Grundt H , Nilsen DW , Mansoor MA , Nordøy A . Increased lipid peroxidation long-term intervention high dose n-3 fatty acid ( PUFAs ) follow acute myocardial infarction . Eur J Clin Nutr . 2003 Jun ; 57 ( 6 ) :793-800 . 4 . Grundt H , Hetland Ø , Nilsen DW . Changes tissue factor activate factor XII follow acute myocardial infarction uninfluenced high dos n-3 polyunsaturated fatty acid . Thromb Haemost . 2003 Apr ; 89 ( 4 ) :752-9 . 5 . Grundt H , Nilsen DW , Hetland Ø , Mansoor MA . Clinical outcome atherothrombogenic risk profile prolong wash-out follow long-term treatment high dose n-3 PUFAs patient acute myocardial infarction . Clin Nutr . 2004 Aug ; 23 ( 4 ) :491-500 . 6 . Grundt H , Nilsen DW , Hetland Ø , Valente E , Fagertun HE . Activated factor 12 ( FXIIa ) predict recurrent coronary event acute myocardial infarction . Am Heart J . 2004 Feb ; 147 ( 2 ) :260-6 . 7 . Aarsetøy H , Brügger-Andersen T , Hetland Ø , Grundt H , Nilsen DW . Long term influence regular intake high dose n-3 fatty acid CD40-ligand , pregnancy-associated plasma protein A matrix metalloproteinase-9 follow acute myocardial infarction . Thromb Haemost . 2006 Feb ; 95 ( 2 ) :329-36 . 8 . Brügger-Andersen T , Aarsetøy H , Grundt H , Staines H , Nilsen DW . The long-term prognostic value multiple biomarkers follow myocardial infarction.Thromb Res . 2008 ; 123 ( 1 ) :60-6 . 9 . Aarsetøy H , Valente E , Reine A , Mansoor MA , Grundt H , Nilsen DW . Holotranscobalamin methylmalonic acid prognostic marker follow acute myocardial infarction . Eur J Clin Nutr . 2008 Mar ; 62 ( 3 ) :411-8 . Epub 2007 Mar 7 .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Tocopherols</mesh_term>
	<mesh_term>Vitamin E</mesh_term>
	<mesh_term>Tocotrienols</mesh_term>
	<mesh_term>alpha-Tocopherol</mesh_term>
	<criteria>Verified acute myocardial infarction ( MI ) World Health Organization criterion Age 18 year Discontinuation regular supplementation fishoil product Signed informed consent Assumed noncompliance protocol Expected survival &lt; 2 severe heart failure ( New York Heart Association class IV ) , malignancy , reason Ongoing gastrointestinal bleeding verify stomach ulcer Thrombocytopenia blood platelet &lt; 100 x 10 ' 9/L Liver insufficiency Participation study Residence outside recruitment area study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>n-3 fatty acid</keyword>
	<keyword>randomize double-blind study</keyword>
	<keyword>coronary event</keyword>
	<keyword>serum lipid</keyword>
	<keyword>antithrombotic effect omega-3 fatty acid</keyword>
	<keyword>anti-inflammatory effect omega-3 fatty acid</keyword>
	<keyword>prognostic biomarkers myocardial infarction ( MI ) -patients</keyword>
</DOC>